Clinical Trials Browser

Phase EARLY_PHASE1 × Terminated × Recurrence × Clear all

NCT04034446 2025-06-03

CD19-CD22 Chimeric Antigen Receptor T (CAR-T) Cell for Treatment of B Cell Acute Lymphoblastic Leukemia (B-ALL)

Phase EARLY_PHASE1 Terminated

Burkitt Lymphoma, Recurrence

NCT02623582 2017-10-17

CD123 Redirected Autologous T Cells for AML

Phase EARLY_PHASE1 Terminated

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute